iKang Schedules 2016 Unaudited Third Quarter Earnings Release on March 16, 2017
Feb 27, 2017 13:00 pm UTC| Business
BEIJING, Feb. 27, 2017 -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq:KANG), China’s largest private preventive healthcare services provider, today announced that it will release its unaudited...
ITG Launches Turnkey Research Payment Account Solution
Feb 27, 2017 12:59 pm UTC| Business
NEW YORK and LONDON, Feb. 27, 2017 -- ITG (NYSE:ITG), a leading independent broker and financial technology provider, today announced the rollout of an enhanced Research Payment Account (RPA) solution to enable asset...
EDAP's Ablatherm® Robotic HIFU Treatments Performed at University of Minnesota
Feb 27, 2017 12:31 pm UTC| Business
EDAP's Ablatherm® Robotic HIFU Treatments Performed at University of Minnesota LYON, France, February 27, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced the first...
Feb 27, 2017 12:30 pm UTC| Business
VANCOUVER, British Columbia, Feb. 27, 2017 -- Skyharbour Resources Ltd. (TSX-V:SYH)(OTCQB:SYHBF)(Frankfurt:SC1P) (the “Company”) is pleased to announce the first drill hole of the 2017 winter exploration program on the...
Feb 27, 2017 12:30 pm UTC| Business
LA JOLLA, Calif., Feb. 27, 2017 -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical stage biopharmaceutical company, today announced an oral presentation for its lead product candidate, tipifarnib, at the 15th...
Feb 27, 2017 12:30 pm UTC| Business
BOSTON, Feb. 27, 2017 -- Exonics Therapeutics, Inc., a newly formed biotechnology company focused on developing gene editing technologies like CRISPR/Cas9 to permanently correct a majority of mutations causing Duchenne...
Feb 27, 2017 12:30 pm UTC| Business
DUBLIN, Ireland and TREVOSE, Pa., Feb. 27, 2017 -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare...